Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Shariat

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Prostate Cancer and Prostatic Diseases|September 4, 2013
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomyM Rieken, L A Kluth, E Xylinas, et al.
World Journal of Urology|October 13, 2016
Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tractG J Wirth, A Haitel, M Moschini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 12, 2013
Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinomaM Rieken, E Xylinas, L Kluth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274M D Galsky, J E Gschwend, M I Milowsky, et al.
Actas Urologicas Espanolas|March 17, 2025
Impact of opium on bladder cancer incidence: A systematic review and meta-analysisS Mancon, A Matsukawa, A Cadenar, et al.
British Journal of Cancer|November 22, 2012
Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counsellingE Xylinas, E K Cha, M Sun, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 1, 2014
Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinomaM Rieken, T Schubert, E Xylinas, et al.
Actas Urologicas Espanolas|February 14, 2025
Circulating tumor DNA in muscle-invasive bladder cancer: A systematic reviewA A Grosso, A Cadenar, S Pillozzi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 20, 2020
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [<sup>68</sup>Ga]Ga-PSMA-11 PET/MRIL Papp, C P Spielvogel, B Grubmüller, et al.
Actas Urologicas Espanolas|January 7, 2026
Efficacy and safety of active surveillance and chemoablation in the management of non-muscle invasive bladder cancer (NMIBC): Systematic review and pooled analysis by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working GroupA Saouli, R Contieri, F Quhal, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Prostate Cancer and Prostatic Diseases|September 4, 2013
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomyM Rieken, L A Kluth, E Xylinas, et al.
World Journal of Urology|October 13, 2016
Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tractG J Wirth, A Haitel, M Moschini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 12, 2013
Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinomaM Rieken, E Xylinas, L Kluth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274M D Galsky, J E Gschwend, M I Milowsky, et al.
Actas Urologicas Espanolas|March 17, 2025
Impact of opium on bladder cancer incidence: A systematic review and meta-analysisS Mancon, A Matsukawa, A Cadenar, et al.
British Journal of Cancer|November 22, 2012
Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counsellingE Xylinas, E K Cha, M Sun, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 1, 2014
Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinomaM Rieken, T Schubert, E Xylinas, et al.
Actas Urologicas Espanolas|February 14, 2025
Circulating tumor DNA in muscle-invasive bladder cancer: A systematic reviewA A Grosso, A Cadenar, S Pillozzi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 20, 2020
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [<sup>68</sup>Ga]Ga-PSMA-11 PET/MRIL Papp, C P Spielvogel, B Grubmüller, et al.
Actas Urologicas Espanolas|January 7, 2026
Efficacy and safety of active surveillance and chemoablation in the management of non-muscle invasive bladder cancer (NMIBC): Systematic review and pooled analysis by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working GroupA Saouli, R Contieri, F Quhal, et al.
Pageof 10